Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06443320

Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Centre Hospitalier Intercommunal Robert Ballanger · Academic / Other
Sex
All
Age
3 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).

Detailed description

Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities. Communication tools like PECS or Makaton and social skills groups have shown effectiveness but have limitations, particularly not addressing sensory atypicalities seen in children with ASD. These sensory atypicalities are evident when children watch videos on screens. The idea is to use video to understand the sensory experiences of children with ASD and help them move away from an isolated relationship with screens. New technologies can further isolate children with ASD in their autistic sphere. The hypothesis is that observing these children with screens will provide better understanding of their sensory experiences and improve therapeutic support towards play and interaction with others

Conditions

Interventions

TypeNameDescription
OTHERpatient included in experimental groupe will view the video excerpt, a playtime, a drawing activitiesPatients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Timeline

Start date
2023-12-04
Primary completion
2027-03-04
Completion
2027-03-04
First posted
2024-06-05
Last updated
2025-02-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06443320. Inclusion in this directory is not an endorsement.